Your browser doesn't support javascript.
loading
Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models.
Yin, Xiaoyan; Li, Ying; Bagchus, Wilhelmina; Yalkinoglu, Özkan; Bezuidenhout, Deon; Tappert, Aliona; McCarthy, James; Marquart, Louise; Oeuvray, Claude.
Affiliation
  • Yin X; EMD Serono Research & Development Institute, Inc. (an Affiliate of Merck KGaA), 45 Middlesex Turnpike, Billerica, MA, 01821, USA. xiaoyan.a.yin@emdserono.com.
  • Li Y; EMD Serono Research & Development Institute, Inc. (an Affiliate of Merck KGaA), 45 Middlesex Turnpike, Billerica, MA, 01821, USA.
  • Bagchus W; WMB: Merck Serono S.A (an Affiliate of Merck KGaA), Lausanne, Switzerland.
  • Yalkinoglu Ö; Merck KGaA, Darmstadt, Germany.
  • Bezuidenhout D; WMB: Merck Serono S.A (an Affiliate of Merck KGaA), Lausanne, Switzerland.
  • Tappert A; Merck KGaA, Darmstadt, Germany.
  • McCarthy J; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Marquart L; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Oeuvray C; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Malar J ; 22(1): 199, 2023 Jun 28.
Article in En | MEDLINE | ID: mdl-37381013
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parasites / Malaria, Falciparum / Antimalarials Type of study: Systematic_reviews Limits: Animals / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parasites / Malaria, Falciparum / Antimalarials Type of study: Systematic_reviews Limits: Animals / Humans Language: En Year: 2023 Type: Article